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The vasopressin precursor is composed of 3 domains, namely vasopressin, MSEL-neurophysin and a 
glycopeptide. Processing occurs during axonal transport from hypothaiamus to neuroh~ophysis from 
which the 3 fragments can be isolated. The glycopeptide fragment of the rat vasopressin precursor has been 
purified and sequenced. Despite the fact that rat MSEL-neurophysin is shortened (93 residues instead of 
95 for other mammals), rat glycopeptide has 39 residues, as do the other mammalian glycopeptides, 
suggesting a similar processing. Fifteen substitutions are however observed when compared to ox 
glycopeptide. The C-terminal part of MSEL-neurophysin (residues 77-93) and the glycopeptide are 
encoded by the same exon and the homologies when compared with their bovine counterparts are 58% 
and 62% respectively. In contrast, the central part of rat MSEL-neurophysin (residues lo-76), which is 
encoded by a separate xon, dispiays 96% of homology; vasopressin and the N-terminal part of MSEL- 
neurophysin (residues l-91, encoded by a third exon, are nearly invariant. 
Neurohypophysial glycopeptide sequence 
Rat glycopeptide 
1. INTRODUCTION 
Mammalian vasopressin is a fragment of a 
3-domain precursor that is usually processed into 
vasopressin (9 residues), MSEL-neurophysin 
(93-95 residues) and a glycopeptide (39 residues) 
[l-3]. Rat vasopressin has been identified as 
arginine vasopressin 141, current in most placental 
mammals. Rat MSEL-neurophysin however is 
somewhat different from other rn~rn~i~ 
MSEL-neurophysins, having 93 residues instead of 
95 because of an apparent C-terminal deletion [5]; 
furthermore, a single arginine is found instead of 
the penultimate Arg-Arg sequence typical of 
MSEL-neurophysins [6]. It is therefore of interest 
to characterize the glycopeptide in order to check 
whether the processing has been modified by these 
variations. 
2. MATERIALS AND METHODS 
Freeze-dried posterior pituitary lobes (740 mg, 
Vasopressin-neurophysin precursor 
Exon evolution 
about 1800 glands) are extracted with 0.1 M HCl 
(25 mg/ml) and the supernatant is subjected to a 
molecular sieving on Sephadex G-75 under condi- 
tions described [5]. The fraction corresponding to 
‘crude’ neurophysins (50 mg) is collected and 
chromatographed on a column (0.5 x 38 cm) of 
DEAE-Sephadex A-50 equilibrated with 0.4 M 
pyridine acetate pH 5.9 [5]. The glycopeptide 
filters through the column (8.6 mg) whereas 
neurophysins, retained, are eluted by an ionic 
strength gradient IS]. The glycopeptide, adsorbed 
at pH 7.4 on a column of concanavalin A, appears 
homogeneous. It is split either with trypsin [5] or 
with staphylococcal proteinase [7] and resulting 
peptides are separated by peptide mapping [8]. 
Peptides are analyzed [lOI and amino acid se- 
quences are d~e~ined by a manual Edman pro- 
cedure [lo] either directly or after cleavage by sub- 
tilisin, isolation of sub-fragments and determina- 
tion of their sequences. Phenylthiohydantoin 
amino acids are identified by thin-layer 
chromatography [111. 
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Ala-Arg-Glu-Gln-Ser-Asn-Ala-Thr-Gln-Leu-Asp-Gly-Pro-Ala-Arg-Glu-Leu-Leu-Leu-Arg 
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Leu-Val-Gln-Leu-Ala-Gly-Thr-Gln-Glu-Ser-Val-ASp-Ser-Ala-Lys-Pro-Arg-Val-Tyr 
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Fig.1. Amino acid sequence of rat glycopeptide. Tryptic peptides (Tr-T5) are sequenced either directly or through 
subtilisic subfragments (Tzsr, etc . . . .). Overlapping staphylococcal proteinase peptides (Strto St,) give the alignment of 
the tryptic peptides. 
Table 1 
Amino acid compositions of tryptic peptides of rat glycopeptide 
TI T2 T3 I-4 T5 
(28 nmol) (6.3 nmol) (3.6 nmol) (4.4 nmol) (20 nmol) 
Analysis Sequence Analysis Sequence Analysis Sequence Analysis Sequence Analysis Sequence 
I-Ys 1.00 (1) 
His 
kg 1.00 (1) 1.00 (1) 1.00 (1) 1.02 (1) 
Asp 1.98 (2) 1.18 (1) 
Thr 0.89 (1) 1.02 (1) 
Ser 1.16 (1) 2.16 (2) 
Glu 2.87 (3) 0.75 (1) 3.23 (3) 
Pro 1.15 (1) 1.00 (1) 
GlY 1.20 (1) 1.34 (1) 
Ala 0.62 (1) 2.28 (2) 2.45 (2) 
l/2 cys 
Val 2.18 (2) 1.00 (1) 
Met 
Ile 
Leu 1.13 (1) 2.60 (3) 1.84 (2) 
Tyr 0.50 (1) 
Phe 
CysO3H 
Glucosamine” 2.91 
Number of 
residues 2 13 5 17 2 
Location in 
the sequence l-2 3-15 16-20 21-37 38-39 
* Uncorrected for destruction 
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1 5 10 15 20 
Bovine Ala-Asn-Asp-Arg-Ser-Asn-Ala-Thr-Leu-Leu-ASp-Gly-Pro-Ser-Gly-Ala-Leu-Leu-Leu-Arg 
Ovine - Ser 
Porcine - Ser 
Human - Ser Asn Ala 
Rat - Arg-Glu-Gln Gln Ala-Arg-Glu 
21 25 30 35 39 
Bovine LeU-Va~-Gln-LeU-Ala-Gly-Ala-Pro-Glu-Pro-Ala-Glu-Pro-Ala-Gln-Pro-Gly-Val-Tyr 
Ovine Ala 
Porcine 
Human Phe Asp-Ala - 
Rat Thr-Gin -Ser-Val-Asp-Ser -Lys- Arg- 
Fig.2. Comparison of bovine [ 131, ovine [ 131, porcine [ 131, human [ 141 and rat (here, [ 151) glycopeptides. Solid lines 
indicate residues identical with those of bovine glycopeptide. 
3. RESULTS 
Five tryptic peptides (TI-T5) are isolated and 
analyzed. Amino acid compositions are given in 
table 1. Peptide TT has been detected by a staining 
reaction specific for tyrosine [ 121. Tryptic peptides 
are sequenced either directly or through subtilisic 
peptides derived from TZ (Tzsr, etc.. . .) and T4 
(T4si, etc.. . .). Amino acid sequences are given in 
fig.2. The alignment of the tryptic peptides is 
determined with 3 overlapping peptides (St, to St3) 
obtained by hydrolysis with staphylococcal 
proteinase. 
4. DISCUSSION 
Glycopeptide from vasopressin precursors of ox, 
sheep, pig [ 131 and man [ 141 have already been 
characterized. All of them, as rat glycopeptide, 
have 39 residues and display a great homology 
(fig.2). The MSEL-neurophysins of these species 
have 95 residues except those of rat and man, 
which have only 93 residues [6]. In bovine 
vasopressin precursor, an arginyl residue separates 
MSEL-neurophysin from glycopeptide [2] and it is 
assumed that cleavage of the precursor by a 
trypsin-like enzyme occurs after this arginine, 
which is subsequently removed from MSEL- 
neurophysin moiety by a carboxypeptidase B. 
Recently the gene for the rat vasopressin- 
neurophysin precursor has been isolated and the 
precursor amino acid sequence has been deduced 
[15]. It appears that the rat vasopressin precursor 
includes the arginine vasopressin and the MSEL- 
neurophysin identified in [4,5], the two domains 
being separated by a sequence Gly-Lys-Arg, 
usually involved in the mechanism of C-terminal 
amide formation [16]. On the other hand, MSEL- 
neurophysin is separated from the glycopeptide by 
a single arginine as in the bovine vasopressin 
precursor despite the shortening of rat MSEL- 
neurophysin. The sequence deduced for the 
glycopeptide [15] is in complete agreement with 
that determined directly on the 39-residue 
fragment. 
When compared with bovine vasopressin precur- 
sor, rat vasopressin precursor displays 11 substitu- 
tions and 2 deletions in the MSEL-neurophysin 
moiety (about 86% of homology) and 15 substitu- 
tions in the glycopeptide moiety (about 62% of 
homology). However the hyper-variable C- 
terminal part of MSEL-neurophysin (residues 
77-93) and the glycopeptide are encoded by the 
same exon C [ 151 and the homology in this part of 
MSEL-neurophysin (58%) is very similar to that 
found for the glycopeptide. The 3 exons of the 
vasopressin gene [ 151 seem to have different evolu- 
tionary drifts since exon B that encodes the central 
part of MSEL-neurophysin (residues lo-76), is 
nearly invariant and exon A that encodes the signal 
peptide, arginine vasopressin and the N-terminal 
sequence of MSEL-neurophysin (residue l-9) 
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displays a few variations in its first and third parts 
[6,15], but very rarely in the hormonal part [17]. 
The substitutions observed in the vasopressin 
precursor are hardly explained by selective 
pressure but seem rather relevant to the neutral 
drift f 181. 
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